Contrarily, stroke considerably elevated global PARP activity in the PTA muscle of WT mice, but not in the PTA muscle of SirT1+/+ mice, which inhibited PARP activity, as evidenced by reduced levels of global protein parylation (Figure 3B). The gene discussed is SIRT1; the disease is stroke disorder.